Skip to main content
. 2009 Feb 9;27(8):1268–1274. doi: 10.1200/JCO.2008.17.5984

Fig 3.

Fig 3.

Mean (± standard deviation) plasma concentration versus time profile for erlotinib (OSI-774) after oral administration of erlotinib in cycle 1, day 8: erlotinib 150 mg without enzyme-inducing anticonvulsants (EIAEDs) and erlotinib 300 mg with EIAEDs.